Analysis of the cartilage proteome from three different mouse models of genetic skeletal diseases reveals common and discrete disease signatures

Biology Open

Volumn 2, Issue 8, 2013, Pages 802-811

  Bell, Peter A ^a   Wagener, Raimund ^b,c   Zaucke, Frank ^b   Koch, Manuel ^b,c,d   Selley, Julian ^a   Warwood, Stacey ^a   Knight, David ^a   Boot Handford, Raymond P ^a   Thornton, David J ^a   Briggs, Michael D ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b Center for Molecular Medicine   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Cartilage; Genetic skeletal disease; Multiple epiphyseal dysplasia; Proteomics; Pseudoachondroplasia

Indexed keywords

EID: 85017285409     PISSN: None     EISSN: 20466390     Source Type: Journal    
DOI: 10.1242/bio.20135280     Document Type: Article

References (50)

1. Agarwal, P., Zwolanek, D., Keene, D. R., Schulz, J. N., Blumbach, K., Heinegard, D., Zaucke, F., Paulsson, M., Krieg, T., Koch, M. et al. (2012). Collagen XII and XIV, new partners of cartilage oligomeric matrix protein in the skin extracellular matrix suprastructure. J. Biol. Chem. 287, 22549-22559.
2. Ansorge, H. L., Meng, X., Zhang, G., Veit, G., Sun, M., Klement, J. F., Beason, D. P., Soslowsky, L. J., Koch, M. and Birk, D. E. (2009). Type XIV collagen regulates fibrillogenesis: premature collagen fibril growth and tissue dysfunction in null mice. J. Biol. Chem. 284, 8427-8438.
3. Bell, P. A., Piróg, K. A., Fresquet, M., Thornton, D. J., Boot-Handford, R. P. and Briggs, M. D. (2012). Loss of matrilin 1 does not exacerbate the skeletal phenotype in a mouse model of multiple epiphyseal dysplasia caused by a Matn3 V194D mutation. Arthritis Rheum. 64, 1529-1539.
4. Belluoccio, D., Wilson, R., Thornton, D. J., Wallis, T. P., Gorman, J. J. and Bateman, J. F. (2006). Proteomic analysis of mouse growth plate cartilage. Proteomics 6, 6549-6553.
5. Briggs, M. D. and Chapman, K. L. (2002). Pseudoachondroplasia and multiple epiphyseal dysplasia: mutation review, molecular interactions, and genotype to phenotype correlations. Hum. Mutat. 19, 465-478.
6. Budde, B., Blumbach, K., Ylöstalo, J., Zaucke, F., Ehlen, H. W., Wagener, R., Ala- Kokko, L., Paulsson, M., Bruckner, P. and Grä ssel, S. (2005). Altered integration of matrilin-3 into cartilage extracellular matrix in the absence of collagen IX. Mol. Cell. Biol. 25, 10465-10478.
7. Dennis, G. Jr, Sherman, B. T., Hosack, D. A., Yang, J., Gao, W., Lane, H. C. and Lempicki, R. A. (2003). DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 4, P3.
8. Di Cesare, P., Hauser, N., Lehman, D., Pasumarti, S. and Paulsson, M. (1994). Cartilage oligomeric matrix protein (COMP) is an abundant component of tendon. FEBS Lett. 354, 237-240.
9. Ehlen, H. W., Sengle, G., Klatt, A. R., Talke, A., Mü ller, S., Paulsson, M. and Wagener, R. (2009). Proteolytic processing causes extensive heterogeneity of tissue matrilin forms. J. Biol. Chem. 284, 21545-21556.
10. Fässler, R., Schnegelsberg, P. N., Dausman, J., Shinya, T., Muragaki, Y., McCarthy, M. T., Olsen, B. R. and Jaenisch, R. (1994). Mice lacking alpha 1 (IX) collagen develop noninflammatory degenerative joint disease. Proc. Natl. Acad. Sci. USA 91, 5070-5074.
11. Fresquet, M., Jowitt, T. A., Ylöstalo, J., Coffey, P., Meadows, R. S., Ala-Kokko, L., Thornton, D. J. and Briggs, M. D. (2007). Structural and functional characterization of recombinant matrilin-3 A-domain and implications for human genetic bone diseases. J. Biol. Chem. 282, 34634-34643.
12. Fresquet, M., Jowitt, T. A., Stephen, L. A., Ylöstalo, J. and Briggs, M. D. (2010). Structural and functional investigations of Matrilin-1 A-domains reveal insights into their role in cartilage ECM assembly. J. Biol. Chem. 285, 34048-34061.
13. Hansen, U., Platz, N., Becker, A., Bruckner, P., Paulsson, M. and Zaucke, F. (2011). A secreted variant of cartilage oligomeric matrix protein carrying a chondrodysplasiacausing mutation (p.H587R) disrupts collagen fibrillogenesis. Arthritis Rheum. 63, 159-167.
14. Hauser, N. and Paulsson, M. (1994). Native cartilage matrix protein (CMP). A compact trimer of subunits assembled via a coiled-coil alpha-helix. J. Biol. Chem. 269, 25747- 25753.
15. Hills, R., Mazzarella, R., Fok, K., Liu, M., Nemirovskiy, O., Leone, J., Zack, M. D., Arner, E. C., Viswanathan, M., Abujoub, A. et al. (2007). Identification of an ADAMTS-4 cleavage motif using phage display leads to the development of fluorogenic peptide substrates and reveals matrilin-3 as a novel substrate. J. Biol. Chem. 282, 11101-11109.
16. Holden, P., Meadows, R. S., Chapman, K. L., Grant, M. E., Kadler, K. E. and Briggs, M. D. (2001). Cartilage oligomeric matrix protein interacts with type IX collagen, and disruptions to these interactions identify a pathogenetic mechanism in a bone dysplasia family. J. Biol. Chem. 276, 6046-6055.
17. Huijing, P. A., Voermans, N. C., Baan, G. C., Busé, T. E., van Engelen, B. G. and de Haan, A. (2010). Muscle characteristics and altered myofascial force transmission in tenascin-X-deficient mice, a mouse model of Ehlers-Danlos syndrome. J. Appl. Physiol. 109, 986-995.
18. Jackson, G. C., Mittaz-Crettol, L., Taylor, J. A., Mortier, G. R., Spranger, J., Zabel, B., Le Merrer, M., Cormier-Daire, V., Hall, C. M., Offiah, A. et al. (2012). Pseudoachondroplasia and multiple epiphyseal dysplasia: A 7-year comprehensive analysis of the known disease genes identify novel and recurrent mutations and provides an accurate assessment of their relative contribution. Hum. Mutat. 33, 144- 157.
19. Klatt, A. R., Nitsche, D. P., Kobbe, B., Mörgelin, M., Paulsson, M. and Wagener, R. (2000). Molecular structure and tissue distribution of matrilin-3, a filamentforming extracellular matrix protein expressed during skeletal development. J. Biol. Chem. 275, 3999-4006.
20. Klatt, A. R., Nitsche, D. P., Kobbe, B., Macht, M., Paulsson, M. and Wagener, R. (2001). Molecular structure, processing, and tissue distribution of matrilin-4. J. Biol. Chem. 276, 17267-17275.
21. Klatt, A. R., Paul-Klausch, B., Klinger, G., Kü hn, G., Renno, J. H., Banerjee, M., Malchau, G. and Wielckens, K. (2009). A critical role for collagen II in cartilage matrix degradation: collagen II induces pro-inflammatory cytokines and MMPs in primary human chondrocytes. J. Orthop. Res. 27, 65-70.
22. Leighton, M. P., Nundlall, S., Starborg, T., Meadows, R. S., Suleman, F., Knowles, L., Wagener, R., Thornton, D. J., Kadler, K. E., Boot-Handford, R. P. et al. (2007). Decreased chondrocyte proliferation and dysregulated apoptosis in the cartilage growth plate are key features of a murine model of epiphyseal dysplasia caused by a matn3 mutation. Hum. Mol. Genet. 16, 1728-1741.
23. Li, H., Haudenschild, D. R., Posey, K. L., Hecht, J. T., Di Cesare, P. E. and Yik, J. H. N. (2011). Comparative analysis with collagen type II distinguishes cartilage oligomeric matrix protein as a primary TGFb-responsive gene. Osteoarthritis Cartilage 19, 1246-1253.
24. Liu, H., Sadygov, R. G. and Yates, J. R. 3rd. (2004). A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal. Chem. 76, 4193-4201.
25. Lundgren, D. H., Hwang, S. I., Wu, L. and Han, D. K. (2010). Role of spectral counting in quantitative proteomics. Expert Rev. Proteomics 7, 39-53.
26. Mann, H. H., Ozbek, S., Engel, J., Paulsson, M. and Wagener, R. (2004). Interactions between the cartilage oligomeric matrix protein and matrilins. Implications for matrix assembly and the pathogenesis of chondrodysplasias. J. Biol. Chem. 279, 25294- 25298.
27. Mao, J. R., Taylor, G., Dean, W. B., Wagner, D. R., Afzal, V., Lotz, J. C., Rubin, E. M. and Bristow, J. (2002). Tenascin-X deficiency mimics Ehlers-Danlos syndrome in mice through alteration of collagen deposition. Nat. Genet. 30, 421-425.
28. Mendler, M., Eich-Bender, S. G., Vaughan, L., Winterhalter, K. H. and Bruckner, P. (1989). Cartilage contains mixed fibrils of collagen types II, IX, and XI. J. Cell Biol. 108, 191-197.
29. Nicolae, C., Ko, Y. P., Miosge, N., Niehoff, A., Studer, D., Enggist, L., Hunziker, E. B., Paulsson, M., Wagener, R. and Aszodi, A. (2007). Abnormal collagen fibrils in cartilage of matrilin-1/matrilin-3-deficient mice. J. Biol. Chem. 282, 22163-22175.
30. Nundlall, S., Rajpar, M. H., Bell, P. A., Clowes, C., Zeeff, L. A., Gardner, B., Thornton, D. J., Boot-Handford, R. P. and Briggs, M. D. (2010). An unfolded protein response is the initial cellular response to the expression of mutant matrilin-3 in a mouse model of multiple epiphyseal dysplasia. Cell Stress Chaperones 15, 835- 849.
31. Patel, L., Sun, W., Glasson, S. S., Morris, E. A., Flannery, C. R. and Chockalingam, P. S. (2011). Tenascin-C induces inflammatory mediators and matrix degradation in osteoarthritic cartilage. BMC Musculoskelet. Disord. 12, 164.
32. Pecora, F., Forlino, A., Gualeni, B., Lupi, A., Giorgetti, S., Marchese, L., Stoppini, M., Tenni, R., Cetta, G. and Rossi, A. (2007). A quantitative and qualitative method for direct 2-DE analysis of murine cartilage. Proteomics 7, 4003-4007.
33. Pham, T. V., Piersma, S. R., Warmoes, M. and Jimenez, C. R. (2010). On the betabinomial model for analysis of spectral count data in label-free tandem mass spectrometry-based proteomics. Bioinformatics 26, 363-369.
34. Piecha, D., Muratoglu, S., Mörgelin, M., Hauser, N., Studer, D., Kiss, I., Paulsson, M. and Deák, F. (1999). Matrilin-2, a large, oligomeric matrix protein, is expressed by a great variety of cells and forms fibrillar networks. J. Biol. Chem. 274, 13353-13361.
35. Piróg, K. A. and Briggs, M. D. (2010). Skeletal dysplasias associated with mild myopathy-A clinical and molecular review. J. Biomed. Biotechnol. 2010, 686457.
36. Piróg, K. A., Jaka, O., Katakura, Y., Meadows, R. S., Kadler, K. E., Boot-Handford, R. P. and Briggs, M. D. (2010). A mouse model offers novel insights into the myopathy and tendinopathy often associated with pseudoachondroplasia and multiple epiphyseal dysplasia. Hum. Mol. Genet. 19, 52-64.
37. Piróg-Garcia, K. A., Meadows, R. S., Knowles, L., Heinegard, D., Thornton, D. J., Kadler, K. E., Boot-Handford, R. P. and Briggs, M. D. (2007). Reduced cell proliferation and increased apoptosis are significant pathological mechanisms in a murine model of mild pseudoachondroplasia resulting from a mutation in the Cterminal domain of COMP. Hum. Mol. Genet. 16, 2072-2088.
38. Poulet, B., Ulici, V., Stone, T. C., Pead, M., Gburcik, V., Constantinou, E., Palmer, D. B., Beier, F., Timmons, J. A. and Pitsillides, A. A. (2012). Time-series transcriptional profiling yields new perspectives on susceptibility to murine osteoarthritis. Arthritis Rheum. 64, 3256-3266.
39. Schalkwijk, J., Zweers, M. C., Steijlen, P. M., Dean, W. B., Taylor, G., van Vlijmen, I. M., van Haren, B., Miller, W. L. and Bristow, J. (2001). A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency. N. Engl. J. Med. 345, 1167-1175.
40. Schmitz, M., Niehoff, A., Miosge, N., Smyth, N., Paulsson, M. and Zaucke, F. (2008). Transgenic mice expressing D469Delta mutated cartilage oligomeric matrix protein (COMP) show growth plate abnormalities and sternal malformations. Matrix Biol. 27, 67-85.
41. Sofat, N., Robertson, S. D., Hermansson, M., Jones, J., Mitchell, P. and Wait, R. (2012). Tenascin-C fragments are endogenous inducers of cartilage matrix degradation. Rheumatol. Int. 32, 2809-2817.
42. Suleman, F., Gualeni, B., Gregson, H. J., Leighton, M. P., Piróg, K. A., Edwards, S., Holden, P., Boot-Handford, R. P. and Briggs, M. D. (2012). A novel form of chondrocyte stress is triggered by a COMP mutation causing pseudoachondroplasia. Hum. Mutat. 33, 218-231.
43. Svensson, L., Aszódi, A., Heinegard, D., Hunziker, E. B., Reinholt, F. P., Fässler, R. and Oldberg, A. (2002). Cartilage oligomeric matrix protein-deficient mice have normal skeletal development. Mol. Cell. Biol. 22, 4366-4371.
44. van der Kraan, P. M., Blaney Davidson, E. N. and van den Berg, W. B. (2010). A role for age-related changes in TGFbeta signaling in aberrant chondrocyte differentiation and osteoarthritis. Arthritis Res. Ther. 12, 201.
45. Veit, G., Hansen, U., Keene, D. R., Bruckner, P., Chiquet-Ehrismann, R., Chiquet, M. and Koch, M. (2006). Collagen XII interacts with avian tenascin-X through its NC3 domain. J. Biol. Chem. 281, 27461-27470.
46. Voermans, N. C., Verrijp, K., Eshuis, L., Balemans, M. C., Egging, D., Sterrenburg, E., van Rooij, I. A., van der Laak, J. A., Schalkwijk, J., van der Maarel, S. M. et al. (2011). Mild muscular features in tenascin-X knockout mice, a model of Ehlers-danlos syndrome. Connect. Tissue Res. 52, 422-432.
47. Warman, M. L., Cormier-Daire, V., Hall, C., Krakow, D., Lachman, R., LeMerrer, M., Mortier, G., Mundlos, S., Nishimura, G., Rimoin, D. L. et al. (2011). Nosology and classification of genetic skeletal disorders: 2010 revision. Am. J. Med. Genet. A. 155, 943-968.
48. Wiberg, C., Klatt, A. R., Wagener, R., Paulsson, M., Bateman, J. F., Heinegard, D. and Mörgelin, M. (2003). Complexes of matrilin-1 and biglycan or decorin connect collagen VI microfibrils to both collagen II and aggrecan. J. Biol. Chem. 278, 37698-37704.
49. Wilson, R., Whitelock, J. M. and Bateman, J. F. (2009). Proteomics makes progress in cartilage and arthritis research. Matrix Biol. 28, 121-128.
50. Wilson, R., Norris, E. L., Brachvogel, B., Angelucci, C., Zivkovic, S., Gordon, L., Bernardo, B. C., Stermann, J., Sekiguchi, K., Gorman, J. J. et al. (2012). Changes in the chondrocyte and extracellular matrix proteome during post-natal mouse cartilage development. Mol. Cell. Proteomics 11, M111.014159.